Conversely, two studies by Miranda found that CYP2D6 status was not predictive of cognitive response to donepezil at 1 year in Brazilian AD and mixed dementia patients (Miranda et al., 2015, 2017). This evidence concerns the gene CYP2D6 and Alzheimer disease.